Pfizer 5 XNB (Inlyta 5 mg)

Generic Name: axitinib

Pill imprint Pfizer 5 XNB has been identified as Inlyta 5 mg.

Inlyta is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for Pfizer 5 XNB (Inlyta 5 mg)

Inlyta 5 mg Pfizer 5 XNB
Inlyta
Generic Name:
axitinib
Imprint:
Pfizer
5 XNB
Strength:
5 mg
Color:
Red
Shape:
Three-sided
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pfizer Inc.
National Drug Code (NDC):
00069-0151
Inactive Ingredients:
microcrystalline cellulose
lactose monohydrate
croscarmellose sodium
magnesium stearate
titanium dioxide
triacetin
ferric oxide red
hypromellose 2910 (15000 mPa.s)

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web4)